Investor Overview At Gilead we are inspired by the opportunity to address unmet medical needs for patients living with life-threatening diseases around the world. Stock Quote Stock Quote Volume: Nov 15, 2019 4:24 PM EST Latest News November 9, 2019 New Data on Filgotinib in Rheumatoid Arthritis (RA) Demonstrate Durable Efficacy and Safety Profile November 8, 2019 Gilead Presents Data on Investigational HIV-1 Capsid Inhibitor GS-6207 as a Potential Component of Long-Acting HIV Therapy November 8, 2019 Data Showing Potential for Machine Learning to Advance Understanding of Nonalcoholic Steatohepatitis (NASH) Presented at the Liver Meeting® 2019 View All Events Oct 24, 2019 at 4:30 PM EDT Third Quarter 2019 Gilead Sciences Earnings Conference Call Sep 10, 2019 at 10:00 AM EDT Gilead Sciences at the Morgan Stanley Global Healthcare Conference Jul 30, 2019 at 4:30 PM EDT Second Quarter 2019 Gilead Sciences Earnings Conference Call View All
